Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Cyclically Adjusted FCF per Share: ¥-0.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600222 Henan Taloph Pharmaceutical Stock Co Ltd SHSE:600222
60 GF Score
Price ¥7.44
GF Value ¥4.91
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted FCF per Share?

Henan Taloph Pharmaceutical Stock Co SHSE:600222 -0.53% 60 Cyclically Adjusted FCF per Share is ¥-0.07 as of Mar. 2026. GuruFocus rates SHSE:600222 with a GF Score™ of 60/100 and a GF Value™ of ¥4.91 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Henan Taloph Pharmaceutical Stock Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.363. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.07 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Henan Taloph Pharmaceutical Stock Co was 37.00% per year. The lowest was -14.50% per year. And the median was 4.55% per year.

As of today (2026-08-05), Henan Taloph Pharmaceutical Stock Co's current stock price is ¥7.44. Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥-0.07. Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Henan Taloph Pharmaceutical Stock Co was 896.00. The lowest was 345.50. And the median was 718.00.


Henan Taloph Pharmaceutical Stock Co  (SHSE:600222) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Henan Taloph Pharmaceutical Stock Co was 896.00. The lowest was 345.50. And the median was 718.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted FCF per Share Related Terms


Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted FCF per Share Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 -0.03 -0.01 -0.04 -0.04

Henan Taloph Pharmaceutical Stock Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.04 -0.04 -0.04 -0.07

SHSE:600222 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600222
60GF Score
Henan Taloph Pharmaceutical Stock Co Ltd SHSE:600222
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Taloph Pharmaceutical Stock Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Henan Taloph Pharmaceutical Stock Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.363/116.3033*116.3033
=-0.363

Current CPI (Mar. 2026) = 116.3033.

Henan Taloph Pharmaceutical Stock Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.085 101.400 -0.097
201609 -0.028 102.400 -0.032
201612 0.187 102.600 0.212
201703 -0.048 103.200 -0.054
201706 -0.001 103.100 -0.001
201709 -0.029 104.100 -0.032
201712 0.038 104.500 0.042
201803 -0.075 105.300 -0.083
201806 0.002 104.900 0.002
201809 0.075 106.600 0.082
201812 0.092 106.500 0.100
201903 -0.075 107.700 -0.081
201906 -0.108 107.700 -0.117
201909 -0.062 109.800 -0.066
201912 0.128 111.200 0.134
202003 -0.011 112.300 -0.011
202006 -0.007 110.400 -0.007
202009 -0.041 111.700 -0.043
202012 0.061 111.500 0.064
202103 -0.087 112.662 -0.090
202106 0.072 111.769 0.075
202109 0.075 112.215 0.078
202112 0.048 113.108 0.049
202203 -0.282 114.335 -0.287
202206 0.129 114.558 0.131
202209 -0.023 115.339 -0.023
202212 -0.159 115.116 -0.161
202303 -0.180 115.116 -0.182
202306 -0.007 114.558 -0.007
202309 0.042 115.339 0.042
202312 0.148 114.781 0.150
202403 -0.214 115.227 -0.216
202406 0.036 114.781 0.036
202409 -0.012 115.785 -0.012
202412 0.053 114.893 0.054
202503 0.012 115.116 0.012
202506 -0.223 114.907 -0.226
202509 0.031 115.471 0.031
202512 0.230 115.832 0.231
202603 -0.363 116.303 -0.363

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥-0.07 mean?
Henan Taloph Pharmaceutical Stock Co (SHSE:600222) has a Cyclically Adjusted FCF per Share of ¥-0.07 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors.
Is Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted FCF per Share too high?
Henan Taloph Pharmaceutical Stock Co's current Cyclically Adjusted FCF per Share is ¥-0.07. Overall, Henan Taloph Pharmaceutical Stock Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted FCF per Share compare to ZTS?
Henan Taloph Pharmaceutical Stock Co's Cyclically Adjusted FCF per Share of ¥-0.07 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Henan Taloph Pharmaceutical Stock Co and its competitors. Henan Taloph Pharmaceutical Stock Co's current Cyclically Adjusted FCF per Share is ¥-0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Taloph Pharmaceutical Stock Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co (SHSE:600222) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.91, compared to a current price of ¥7.44 — trading 51.5% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥-0.07. Henan Taloph Pharmaceutical Stock Co's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Henan Taloph Pharmaceutical Stock Co (SHSE:600222), the current Cyclically Adjusted FCF per Share is ¥-0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Taloph Pharmaceutical Stock Co stock appears to be overvalued. The current stock price of ¥7.44 is trading 51.5% above its estimated GF Value™ of ¥4.91. GuruFocus considers Henan Taloph Pharmaceutical Stock Co to be Significantly Overvalued.

Key valuation signals for SHSE:600222:

  • Cyclically Adjusted FCF per Share: ¥-0.07
  • GF Value™: ¥4.91 vs. price of ¥7.44 (51.5% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Henan Taloph Pharmaceutical Stock Co Business Description

Address No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in pharmaceutical manufacturing and pharmaceutical research and development services, including pharmaceutical preparations, Chinese herbal medicine slices, and pharmaceutical research and development services. The company's pharmaceutical preparation business is mainly based on oral Chinese medicine preparations, and its treatment areas cover the respiratory system, cardiovascular and cerebrovascular system, digestive system, and nervous system.
60GF Score

Get the complete analysis for SHSE:600222

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.44
Price
¥4.91
GF Value